When LTD 53 was applied to thePC-3 PSMA(−) tumor, its antitumor effect was significantlyweaker, and TGI for the whole follow-up period did not exceed 37.7%.Also, in general, LTD 53 was less toxic than docetaxel,which was used as a control. Here, FOLH1 is linked to neoplasm.